CLPTM1 Recombinant Antibody, PE-Cy7 Conjugated

Product Specifications

Background

Involved in GABAergic but not glutamatergic transmission. Binds and traps GABAA receptors in the endoplasmic reticulum (ER) . Modulates postsynaptic GABAergic transmission, and therefore inhibitory neurotransmission, by reducing the plasma membrane expression of these receptors. Altered GABAergic signaling is one among many causes of cleft palate.

Synonyms

HS9; N14.

Gene ID

1209

Swiss Prot

O96005

Host

Rabbit

Cross Reactivity

Human

Target

CLPTM1

Clonality

Recombinant

Conjugation

PE-Cy7

Source

KLH conjugated synthetic peptide derived from human Putative lipid scramblase CLPTM1

Applications

WB, Flow-Cyt

Purification

Purified by Protein A.

Excitation Emission

488nm/780nm

Concentration

Lot dependent

Dilution

WB (1:300-5000), Flow-Cyt (1ug/Test)

Buffer

Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Modification

Unmodified

Storage Conditions

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Product Datasheet

https://www.biossantibodies.com/datasheets/bsm-62519R-PE-Cy7

Gene ID URL